Zepbound Bests Wegovy for Weight Loss in New Trial

Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical trial funded by Lilly. “Given…

read more

Even Minutes-Long Exercise ‘Bursts’ Can Help Women’s Hearts

Take the stairs. Tote heavy shopping bags. Walk up that hill. Play tag with a kid or a pet. Weaving these tiny bursts of vigorous…

read more

Crisis Pregnancy Centers Offer Dubious Advice on ‘Abortion Pill Reversal’

So-called crisis pregnancy centers, often created with an anti-abortion agenda, are providing pregnant women some questionable medical advice alongside potentially helpful services, a new study…

read more

Drinking Lots of Water Really Is Good for You, Study Finds

The collected evidence is in, and drinking about eight cups of water per day is, in fact, good for you. So says a University of…

read more

Premature Birth Could Impact Life Span for Decades

Premature babies not only face serious and immediate health consequences: New research shows they are also more likely to die early, a risk that persists…

read more

Some HRT Pills May Pose Special Risk for Blood Clots

Certain hormone replacement therapy pills appear to increase the risk of heart disease and serious blood clots in women going through menopause, a new study…

read more

U.S. Abortion Numbers Dipped Slightly in 2022

The rate and number of abortions among U.S. women took a slight dip in 2022 compared to 2021, according to the latest data from the…

read more

Zepbound Slashes Diabetes Risk in Obese Users

The cutting-edge weight-loss drug Zepbound can protect obese people from developing type 2 diabetes, a new clinical trial has found. Zepbound reduced the risk of…

read more

Holiday Travel With a Loved One With Dementia: An Expert Offers Tips

WEDNESDAY, Nov. 27, 2024 — Thanksgiving travel is a must for millions of Americans, but those plans will be complicated for some because they’re traveling…

read more

Biden Will Move to Have Medicare, Medicaid Cover GLP-1 Weight-Loss Meds

The outgoing Biden administration will propose that pricey GLP-1 obesity medications such as semaglutide (Wegovy), and tirzepatide (Zepbound) be covered by Medicare and Medicaid. However,…

read more

Cold Plunge or Hot Bath? What’s Best for Ailing Muscles?

It’s common to find a pitcher soaking their elbow in an ice bucket following a baseball game, in an effort to save their arm for…

read more

Study Finds GLP-1 Meds Can Also Help the Kidneys

The potential health benefits of GLP-1 diabetes and weight loss meds keep piling up: New research shows they may also shield your kidneys from harm.…

read more